Lunglife Ai Share News

LLAI.L
Share Price LLAI.L
Charts LLAI.L
Trades LLAI.L
History Compare
LLAI.L LLAI.L
Share News LLAI.L
RNS LLAI.L
Accounts

Lunglife strikes strategic partnership with Circulogene Theranostics

17th Apr 2025 10:47

(Sharecast News) - Clinical diagnostics firm Lunglife said on Thursday that it has entered into a conditional exclusive license agreement for the commercial distribution of its LungLB test in the US.

LungLife AI upbeat on progress with LungLB test

19th Nov 2024 12:43

(Sharecast News) - Lung cancer diagnostics developer LungLife AI reported significant progress in the commercialisation of its 'LungLB' test on Tuesday, which was designed to facilitate early detection and improve patient outcomes.

LungLife test secures Medicare coverage determination

16th Aug 2024 10:10

(Sharecast News) - Lung cancer diagnostic technology developer LungLife AI announced the finalisation of Medicare coverage for its molecular risk-stratification test, LungLB, aimed at evaluating indeterminate pulmonary nodules, on Friday.

Top Risers

Share	Price	Change
Sunda Energy (SNDA)	2.90	9900%
Design Group (IGR)	69.00	23.21%
Synthomer (SYNT)	61.60	22.71%
Image Scan Holdings (IGE)	1.95	21.87%
Proteome (PRM)	1.68	18.73%

Top Fallers

Share	Price	Change
Engage Xr (EXR)	0.14	-30%
Caledonian Hold (CHP)	0.0027	-15.63%
Celsius Resources Limited (CLA)	0.46	-13.21%
Abrdn Property (API)	1.605	-11.81%
Built Cybernet (BUC)	1.70	-10.53%

Top By Volume

Share	Price	Volume
Quantum Helium (QHE)	0.0305	1,011,404,314
Caledonian Hold (CHP)	0.0027	741,190,520
Premier African Minerals (PREM)	0.016	446,821,970
Empyrean (EME)	0.0625	184,152,630
Ethernity Net (ENET)	0.0024	169,802,439

All prices are delayed by at least 15 minutes. Share Compare cannot be held responsible for the accuracy of share prices shown on this website, and investors should be aware that share prices can go down as well as up. Share Compare does not offer advice, and is not regulated by the Financial Conduct Authority.